Verinomics and Pinnacle Seed have announced a partnership to combine their genetics with the latest breeding and gene editing technologies. The 5-year collaboration aims to develop next-generation leafy green varieties with enhanced disease resistance, improved yield, and superior agronomic profiles to address critical challenges facing growers and the entire supply chain.
The partnership leverages Pinnacle Seed's germplasm resources and market expertise alongside Verinomics' advanced genomic-assisted breeding (Genova) and transgene-free gene editing (Genesis) capabilities, with the commercial launch of initial disease-resistant leafy green varieties expected in 2026.
"This collaboration reflects our shared commitment to accelerating innovation in leafy greens," said Dr. Stephen Dellaporta, Verinomics' Founder. "By joining forces, we're creating an innovation engine that can rapidly identify, develop, and deploy high-value traits—getting improved varieties into growers' hands faster than ever before."
The collaboration directly addresses mounting challenges in leafy green production, including increasing disease pressure, operational constraints, and input costs. New varieties under development will offer better field performance and easier management from field operations to processing facilities.
"At Pinnacle Seed, we've long recognized that the future of leafy green innovation requires both elite genetics and advanced technology," said Mike Vanoli, CEO of Pinnacle Seed. "Partnering with Verinomics has transformed our breeding capabilities to complement our germplasm expertise. Together, we're developing varieties that don't just incrementally improve on existing options — they fundamentally change what's possible in leafy green production."
Pinnacle Seed
www.pinnacleseed.net
Verinomics
[email protected]
www.verinomics.com/